NCT02949011View on ClinicalTrials.gov

Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications

PHASE3CompletedINTERVENTIONAL
Enrollment

2,184

Participants

Timeline

Start Date

January 11, 2017

Primary Completion Date

April 12, 2018

Study Completion Date

April 20, 2018

Conditions
Influenza
Interventions
DRUG

Baloxavir Marboxil

Tablets taken orally

DRUG

Placebo to Baloxavir Marboxil

Matching tablets taken orally

DRUG

Oseltamivir

Capsules taken orally

DRUG

Placebo to Oseltamivir

Matching placebo capsules taken orally

Sponsors

Lead Sponsor

Shionogi
All Listed Sponsors
lead

Shionogi

INDUSTRY